Key Insights

Highlights

No notable highlights available yet

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 3 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
P 2 (1)

Trial Status

Withdrawn1
Recruiting1
Unknown1

Clinical Trials (3)

Showing 3 of 3 trials
NCT07248878Recruiting

Pilot Study for the Generation of Cervical Cancer Organoids From Patients Undergoing Diagnostic Biopsy

NCT03146039Phase 2Withdrawn

Non-Invasive Cervical Cancer Radiotherapy for Stage IB-IVB

NCT02950350Unknown

Clinical Trial of Laparoscopic Pelvic and Para-aortic Lymphadenectomy and Uterine Blood Vessel Blocking for Precision Diagnosis and Treatment in Advanced Cervical Cancer

Showing all 3 trials

Research Network

Activity Timeline